BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38266929)

  • 21. Duration of untreated illness as a predictor of treatment response and remission in obsessive-compulsive disorder.
    Dell'Osso B; Buoli M; Hollander E; Altamura AC
    World J Biol Psychiatry; 2010 Feb; 11(1):59-65. PubMed ID: 20001657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term course of pediatric obsessive-compulsive disorder: 3 years of prospective follow-up.
    Mancebo MC; Boisseau CL; Garnaat SL; Eisen JL; Greenberg BD; Sibrava NJ; Stout RL; Rasmussen SA
    Compr Psychiatry; 2014 Oct; 55(7):1498-504. PubMed ID: 24952937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A 5-year prospective follow-up study of patients with obsessive-compulsive disorder treated with serotonin reuptake inhibitors.
    Cherian AV; Math SB; Kandavel T; Reddy YC
    J Affect Disord; 2014 Jan; 152-154():387-94. PubMed ID: 24157088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Four-year course of quality of life and obsessive-compulsive disorder.
    Remmerswaal KCP; Batelaan NM; Hoogendoorn AW; van der Wee NJA; van Oppen P; van Balkom AJLM
    Soc Psychiatry Psychiatr Epidemiol; 2020 Aug; 55(8):989-1000. PubMed ID: 31541270
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The relationship between cognitions and symptoms in obsessive-compulsive disorder.
    Tibi L; van Oppen P; van Balkom AJLM; Eikelenboom M; Hendriks GJ; Anholt GE
    J Affect Disord; 2018 Jan; 225():495-502. PubMed ID: 28865371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns of remission and relapse in obsessive-compulsive disorder: a 2-year prospective study.
    Eisen JL; Goodman WK; Keller MB; Warshaw MG; DeMarco LM; Luce DD; Rasmussen SA
    J Clin Psychiatry; 1999 May; 60(5):346-51; quiz 352. PubMed ID: 10362449
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term course and outcome of obsessive-compulsive patients after cognitive-behavioral therapy in combination with either fluvoxamine or placebo: a 7-year follow-up of a randomized double-blind trial.
    Rufer M; Hand I; Alsleben H; Braatz A; Ortmann J; Katenkamp B; Fricke S; Peter H
    Eur Arch Psychiatry Clin Neurosci; 2005 Apr; 255(2):121-8. PubMed ID: 15812606
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Attention-Deficit/Hyperactivity Disorder Comorbidity on Phenomenology and Treatment Outcomes of Pediatric Obsessive-Compulsive Disorder.
    Efe A; Kaba D; Canlı M; Temeltürk RD
    J Child Adolesc Psychopharmacol; 2022 Aug; 32(6):337-348. PubMed ID: 35905054
    [No Abstract]   [Full Text] [Related]  

  • 29. [Obsessive-compulsive Disorder: Prevalence, Comorbidity and Remission from the Ages of 20 to 50].
    Angst J; Rufer M; Fineberg N; Ajdacic-Gross V; Rössler W
    Praxis (Bern 1994); 2015 Nov; 104(24):1323-8. PubMed ID: 26602849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Course of obsessive-compulsive disorder in children and adolescents: a prospective follow-up study of 23 Danish cases.
    Thomsen PH; Mikkelsen HU
    J Am Acad Child Adolesc Psychiatry; 1995 Nov; 34(11):1432-40. PubMed ID: 8543510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical relevance of comorbidity in obsessive compulsive disorder: the Netherlands OCD Association study.
    Hofmeijer-Sevink MK; van Oppen P; van Megen HJ; Batelaan NM; Cath DC; van der Wee NJ; van den Hout MA; van Balkom AJ
    J Affect Disord; 2013 Sep; 150(3):847-54. PubMed ID: 23597943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long- term remission status in pediatric obsessive-compulsive disorder: Evaluating the predictive value of symptom severity after treatment.
    Jensen S; Mortensen EL; Skarphedinsson G; Højgaard DR; Hybel KA; Nissen JB; Tord Ivarsson ; Weidle B; Torp NC; Thomsen PH
    Psychiatry Res; 2022 Nov; 317():114906. PubMed ID: 36265194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obsessive-compulsive disorder: a 3-year prospective follow-up study of patients treated with serotonin reuptake inhibitors OCD follow-up study.
    Catapano F; Perris F; Masella M; Rossano F; Cigliano M; Magliano L; Maj M
    J Psychiatr Res; 2006 Sep; 40(6):502-10. PubMed ID: 16904424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empirically-derived response trajectories of intensive residential treatment in obsessive-compulsive disorder: A growth mixture modeling approach.
    Falkenstein MJ; Nota JA; Krompinger JW; Schreck M; Garner LE; Potluri S; Van Kirk N; Ponzini G; Tifft E; Brennan BP; Mathes B; Cattie J; Crosby JM; Elias JA
    J Affect Disord; 2019 Feb; 245():827-833. PubMed ID: 30699866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tic-Related Versus Tic-Free Obsessive-Compulsive Disorder: Clinical Picture and 2-Year Natural Course.
    de Vries FE; Cath DC; Hoogendoorn AW; van Oppen P; Glas G; Veltman DJ; van den Heuvel OA; van Balkom AJ
    J Clin Psychiatry; 2016 Oct; 77(10):e1240-e1247. PubMed ID: 27631146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Outcome of Pediatric Obsessive-Compulsive Disorder: A Meta-Analysis.
    Liu J; Cui Y; Yu L; Wen F; Wang F; Yan J; Yan C; Li Y
    J Child Adolesc Psychopharmacol; 2021 Mar; 31(2):95-101. PubMed ID: 33395547
    [No Abstract]   [Full Text] [Related]  

  • 37. Obsessive compulsive disorder with and without hoarding symptoms: Characterizing differences.
    Boerema YE; de Boer MM; van Balkom AJLM; Eikelenboom M; Visser HA; van Oppen P
    J Affect Disord; 2019 Mar; 246():652-658. PubMed ID: 30611063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Predicting course of illness in patients with severe obsessive-compulsive disorder.
    Garnaat SL; Boisseau CL; Yip A; Sibrava NJ; Greenberg BD; Mancebo MC; McLaughlin NC; Eisen JL; Rasmussen SA
    J Clin Psychiatry; 2015 Dec; 76(12):e1605-10. PubMed ID: 26717540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive and clinical predictors of a long-term course in obsessive compulsive disorder: A machine learning approach in a prospective cohort study.
    Segalàs C; Cernadas E; Puialto M; Fernández-Delgado M; Arrojo M; Bertolin S; Real E; Menchón JM; Carracedo A; Tubío-Fungueiriño M; Alonso P; Fernández-Prieto M
    J Affect Disord; 2024 Apr; 350():648-655. PubMed ID: 38246282
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Episodic obsessive-compulsive disorder and bipolar spectrum disorder: new evidence from a large Italian OCD sample.
    Bramante S; Rigardetto S; Borgogno R; Mehanović E; Pellegrini L; Albert U; Maina G
    Int J Psychiatry Clin Pract; 2023 Nov; 27(4):330-337. PubMed ID: 37401917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.